Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMD
Clinical trial NCT06828211 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06828211
- Sponsor
- OMNIFARMA LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2025-02-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.